These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 7562019

  • 1. Cisplatin increases sensitivity of human leukemic blasts to triazene compounds.
    Piccioni D, D'Atri S, Papa G, Caravita T, Franchi A, Bonmassar E, Graziani G.
    J Chemother; 1995 Jun; 7(3):224-9. PubMed ID: 7562019
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chemosensitivity to triazene compounds and O6-alkylguanine-DNA alkyltransferase levels: studies with blasts of leukaemic patients.
    D'Atri S, Piccioni D, Castellano A, Tuorto V, Franchi A, Lu K, Christiansen N, Frankel S, Rustum YM, Papa G.
    Ann Oncol; 1995 Apr; 6(4):389-93. PubMed ID: 7619755
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide.
    Tentori L, Orlando L, Lacal PM, Benincasa E, Faraoni I, Bonmassar E, D'Atri S, Graziani G.
    Mol Pharmacol; 1997 Aug; 52(2):249-58. PubMed ID: 9271347
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel role of triazenes in haematological malignancies: pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia.
    Caporaso P, Turriziani M, Venditti A, Marchesi F, Buccisano F, Tirindelli MC, Alvino E, Garbin A, Tortorelli G, Toppo L, Bonmassar E, D'Atri S, Amadori S.
    DNA Repair (Amst); 2007 Aug 01; 6(8):1179-86. PubMed ID: 17500047
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of O6-alkylguanine-DNA alkyltransferase and mismatch repair activities on the sensitivity of human melanoma cells to temozolomide, 1,3-bis(2-chloroethyl)1-nitrosourea, and cisplatin.
    Pepponi R, Marra G, Fuggetta MP, Falcinelli S, Pagani E, Bonmassar E, Jiricny J, D'Atri S.
    J Pharmacol Exp Ther; 2003 Feb 01; 304(2):661-8. PubMed ID: 12538819
    [Abstract] [Full Text] [Related]

  • 12. DNA repair enzymes and cytotoxic effects of temozolomide: comparative studies between tumor cells and normal cells of the immune system.
    Pagani E, Pepponi R, Fuggetta MP, Prete SP, Turriziani M, Bonmassar L, Lacal PM, Falcinelli S, Passarelli F, Guadagni F, Alvino E, D'Atri S.
    J Chemother; 2003 Apr 01; 15(2):173-83. PubMed ID: 12797396
    [Abstract] [Full Text] [Related]

  • 13. [Experience with using aclarubicin in the treatment of acute leukemia and blast crisis of chronic myeloid leukemia].
    Savchenko VG, Isaev VG, Abakumov EM, Khoroshko ND, Turkina AG, Sokolov AN, Viadro MM, Navashin SM.
    Antibiot Khimioter; 1992 Jul 01; 37(7):47-9. PubMed ID: 1456812
    [Abstract] [Full Text] [Related]

  • 14. Temozolomide and cisplatin in relapsed/refractory acute leukemia.
    Seiter K, Katragadda S, Ponce D, Rasul M, Ahmed N.
    J Hematol Oncol; 2009 May 22; 2():21. PubMed ID: 19463179
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of CI-973, a platinum analogue, in refractory or relapsed acute leukemia.
    Kantarjian HM, Beran M, O'Brien S, Robertson L, Siddik Z, Yoshida M, Yang LY, Rios MB, Keating MJ, Meyer M.
    Leukemia; 1996 Mar 22; 10(3):396-401. PubMed ID: 8642853
    [Abstract] [Full Text] [Related]

  • 19. In vitro combined effects of a triazene compound and interferon-beta on natural immunity against lymphoblastoid cells: studies at effector and target cell level.
    Bonmassar L, D'Atri S, Turriziani M, Giuliani A.
    Immunopharmacol Immunotoxicol; 1994 Nov 22; 16(4):695-715. PubMed ID: 7876468
    [Abstract] [Full Text] [Related]

  • 20. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
    Gandhi V, Estey E, Du M, Nowak B, Keating MJ, Plunkett W.
    Clin Cancer Res; 1995 Feb 22; 1(2):169-78. PubMed ID: 9815970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.